April 25, 2012
Jack E. Dixon, PhD, Vice President and Chief Scientific Officer of the Howard Hughes Medical Institute, and professor of pharmacology, cellular and molecular medicine, chemistry and biochemistry at the University of California, San Diego has been named a foreign member of the Royal Society.
January 13, 2016
…Alzheimer’s Disease Cooperative Study (ADCS), in collaboration with AC Immune, a biotechnology company based in Switzerland, will test the safety and tolerability of an immunotherapy vaccine that targets Alzheimer’s disease-like characteristics in adults with Down syndrome.
October 20, 2016
Researchers at University of California San Diego School of Medicine have discovered that Zika virus infection leads to modifications of both viral and human genetic material. These modifications — chemical tags known as methyl groups — influence viral replication and the human immune response.
January 26, 2016
…School of Medicine and Veterans Affairs San Diego Healthcare System report data suggesting that e-cigarettes are toxic to human airway cells, suppress immune defenses and alter inflammation, while at the same time boosting bacterial virulence. The mouse study is published January 25 by the Journal of Molecular Medicine.
March 17, 2014
A team of biologists and engineers at the University of California, San Diego has discovered that white blood cells, which repair damaged tissue as part of the body’s immune response, move to inflamed sites by walking in a stepwise manner.
March 5, 2019
Novel study to investigate how sexual trauma increases HIV susceptibility in women.
December 10, 2020
…lab-grown tumor infiltrating lymphocytes (immune cells) to destroy his cancer. New Personalized Immunotherapy Trial Launched Despite COVID-19 Pandemic First patient to receive individualized TIL therapy undergoes treatment at Moores Cancer Center Since 2016, Bernard Thurman has undergone traditional treatments, experimental therapies and surgeries to counter the cancer within him, but…
August 13, 2014
Our immune system copes with a multitude of threats using a mix-and-match system to create millions of different antibodies.
October 12, 2018
…using her unique cancer mutations to boost an anti-tumor immune response.
September 22, 2022
Researchers at UC San Diego have used artificial intelligence-guided tools to pinpoint both a specific type of immune cell as the driver of esophageal cancer and a specific genetic variation that acts as a protective factor in African Americans.
